Other groups have also noted the possibility that ERdj5 could serve as a novel chemotherapeutic target for cancer; the retinoid analogue fenretinide was shown to be a cancer-preventive and chemotherapeutic drug. This evidence concerns the gene DNAJC10 and cancer.